Leptomeningeal disease in oligodendroglial tumors: a population-based study

被引:7
作者
Roldan, Gloria [1 ,2 ]
Chan, Jennifer [1 ,3 ]
Eliasziw, Misha [4 ]
Cairncross, J. Gregory [1 ,5 ]
Forsyth, Peter A. [1 ,2 ,5 ]
机构
[1] Tom Baker Canc Clin, Clark H Smith Brain Tumor Ctr, Alberta Hlth Serv, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Oncol, Calgary, AB T2N 4N2, Canada
[3] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 4N2, Canada
[4] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 4N2, Canada
[5] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada
关键词
Oligodendroglial tumors; Leptomeningeal spread; PHASE-III TRIAL; ANAPLASTIC OLIGODENDROGLIOMA; SURVIVAL; CHEMOTHERAPY; RADIOTHERAPY; PROGNOSIS; 1P;
D O I
10.1007/s11060-011-0551-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this population-based study, we determined the frequency and clinical characteristics of leptomeningeal disease (LMD) developing in the context of oligodendroglial tumors (oligodendrogliomas and oligoastrocytomas). LMD occurred in only 3.9% (8/204) of oligodendroglial tumors and in patients with more recurrences [mean 2.88 vs. 1.27 in LMD and non-LMD, respectively (p = 0.001)]. In contrast to LMD from systemic solid tumors, the median survival following the diagnosis of LMD in oligodendroglial tumors was surprisingly long at 22 months (95% CI 11-33 months). Treatment with oral chemotherapy seemed as effective as more aggressive treatments (e.g. repeat RT or intrathecal chemotherapy) in these patients.
引用
收藏
页码:811 / 815
页数:5
相关论文
共 13 条
[1]   Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas [J].
Bauman, GS ;
Ino, Y ;
Ueki, K ;
Zlatescu, MC ;
Fisher, BJ ;
Macdonald, DR ;
Stitt, L ;
Louis, DN ;
Cairncross, JG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03) :825-830
[2]   Oligodendrogliomas: Molecular Biology and Treatment [J].
Bromberg, Jacolien E. C. ;
van den Bent, Martin J. .
ONCOLOGIST, 2009, 14 (02) :155-163
[3]   Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 [J].
Cairncross, Gregory ;
Berkey, Brian ;
Shaw, Edward ;
Jenkins, Robert ;
Scheithauer, Bernd ;
Brachman, David ;
Buckner, Jan ;
Fink, Karen ;
Souhami, Luis ;
Laperierre, Normand ;
Mehta, Minesh ;
Curran, Walter .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2707-2714
[4]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[5]   Leptomeningeal metastases in the MRI era [J].
Clarke, J. L. ;
Perez, H. R. ;
Jacks, L. M. ;
Panageas, K. S. ;
DeAngelis, L. M. .
NEUROLOGY, 2010, 74 (18) :1449-1454
[6]   Oligodendroglioma and anaplastic oligodendroglioma: Clinical features, treatment, and prognosis [J].
Engelhard, HH ;
Stelea, A ;
Mundt, A .
SURGICAL NEUROLOGY, 2003, 60 (05) :443-456
[7]  
Ino Y, 2001, CLIN CANCER RES, V7, P839
[8]   A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma [J].
Jenkins, Robert B. ;
Blair, Hilary ;
Ballman, Karla V. ;
Giannini, Caterina ;
Arusell, Robert M. ;
Law, Mark ;
Flynn, Heather ;
Passe, Sandra ;
Felten, Sara ;
Brown, Paul D. ;
Shaw, Edward G. ;
Buckner, Jan C. .
CANCER RESEARCH, 2006, 66 (20) :9852-9861
[9]   Incidence of and survival from oligodendroglioma in Denmark, 1943-2002 [J].
Nielsen, Malene Schjonning ;
Christensen, Helle Collatz ;
Kosteljanetz, Michael ;
Johansen, Christoffer .
NEURO-ONCOLOGY, 2009, 11 (03) :311-317
[10]   Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis [J].
Oechsle, Karin ;
Lange-Brock, Victoria ;
Kruell, Andreas ;
Bokemeyer, Carsten ;
de Wit, Maike .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (11) :1729-1735